FDA approves new drug for multiple sclerosis
On March 26, the FDA approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.